Lung Cancer Research Studies
Lung Cancer Research Studies is a research topic within Oncology. Science Explorer counts 38k research works in it since 1950. 17.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers represents a comprehensive exploration of small cell lung cancer, covering topics such as genomic profiles, immunotherapy, chemotherapy, prognostic factors, biomarkers, targeted therapy, clinical trials, metastasis, and tumor markers.
- Small-Cell Lung Cancer
- Genomic Profiles
- Immunotherapy
- Chemotherapy
- Prognostic Factors
- Biomarkers
- Targeted Therapy
- Clinical Trials
- Metastasis
- Tumor Markers
- Research works
- 38k fractional, since 1950
- In the world top 10%
- 6.6k per year above
- Top-10% rate
- 17.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +44% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Lung Cancer Research Studies research?
By volume, China and the United States publish the most (2.7k and 2.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.7k works
- 2 United States 2.1k works
- 3 Japan 633 works
- 4 Italy 377 works
- 5 Germany 319 works
- 6 India 273 works
- 7 France 264 works
- 8 South Korea 229 works
- 9 United Kingdom 222 works
- 10 Spain 219 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Lung Cancer Research Studies research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Lung Cancer Research Studies research, followed by The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 105 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 72 works
- 3 Memorial Sloan Kettering Cancer CenterUnited States 55 works
- 4 Sun Yat-sen UniversityChina 52 works
- 5 Sichuan UniversityChina 48 works
- 6 Shandong First Medical UniversityChina 46 works
- 7 Shanghai Jiao Tong UniversityChina 34 works
- 8 Nanjing Medical UniversityChina 34 works
- 9 Sun Yat-sen University Cancer CenterChina 33 works
- 10 Tianjin Medical University Cancer Institute and HospitalChina 30 works
Who are the leading researchers in Lung Cancer Research Studies?
The most-cited researchers publishing on Lung Cancer Research Studies include Ralph B. D’Agostino, Julie R. Brahmer and Larry Rubinstein.
- 1 Ralph B. D’Agostino United States 3.8k citations
- 2 Julie R. Brahmer United States 3.8k citations
- 3 Larry Rubinstein United States 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Lung Cancer Research Studies research done?
The largest centres of Lung Cancer Research Studies research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Plainview and Kashiwa.
Largest cities, 2022–2025
Where it is the local speciality
- PlainviewUS · 23.2 works35×
- KashiwaJP · 20.4 works26×
Location quotient: how much more of its research is in Lung Cancer Research Studies than the world average.
Where is the best place to study Lung Cancer Research Studies?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Shandong First Medical University and Cornell University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 66.9 | 16.3% | 12.6× | 105 | +100.7% |
| 2 | Shandong First Medical UniversityChina | 57.4 | 14.1% | 21.1× | 46 | +88.1% |
| 3 | Cornell UniversityUnited States | 53.0 | 36.1% | 2.1× | 18 | +135.9% |
| 4 | Shanghai Medical College of Fudan UniversityChina | 52.3 | 19.6% | 16.0× | 11 | +100.4% |
| 5 | Fujian Medical UniversityChina | 52.0 | 11.5% | 8.1× | 24 | +296.1% |
| 6 | Nanjing Medical UniversityChina | 50.7 | 19.0% | 7.8× | 34 | +46.6% |
| 7 | Wenzhou Medical UniversityChina | 50.0 | 18.3% | 6.0× | 18 | +262.3% |
| 8 | Guangzhou Medical UniversityChina | 48.8 | 15.5% | 8.0× | 18 | +118.7% |
| 9 | Southern Medical UniversityChina | 48.5 | 23.1% | 5.6× | 17 | +124.2% |
| 10 | Guangxi Medical UniversityChina | 46.2 | 14.0% | 11.3× | 16 | +43.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Lung Cancer Research Studies research growing?
Output in 2018–2022 was 44% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Lung Cancer Research Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.